Vir Biotechnology Common Stock share price logo

Vir Biotechnology Common Stock

NASDAQ: VIR

Small Cap

$10.04

-0.12

(-1.18%)

Live

as on

Vir Biotechnology Common Stock Stock Performance

as on June 25, 2026 at 4:28 am IST

  • Day's Low

    Day's High

    $10.01
    $10.38
    downward going graph

    0.30%

    Downside

    3.39%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.16
    $11.66
    downward going graph

    58.62%

    Downside

    16.14%

    Upside

    downward going graph

Vir Biotechnology Common Stock share price movements today

Previous Close
$10.16
Open
$10.28
Volume
1.9M
Day's Low - High
$10.01 - $10.38
52 Week Low - High
$4.16 - $11.66

Vir Biotechnology Common Stock Historical Returns

1 Month Return
+ 10.55 %
3 Month Return
+ 18.55 %
1 Year Return
+ 92.79 %
3 Year Return
-58.63 %
5 Year Return
-79.51 %

Vir Biotechnology Common Stock Stock Fundamentals & Key Indicators

Check Vir Biotechnology Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6B

EPS (TTM)

-1.3734

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.58%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-451.0M

Revenue (TTM)

65.5M

Profit Margin

0.00%

Return On Equity TTM

-47.69%

Vir Biotechnology Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vir Biotechnology Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.6B-79.51%NA0.00%NA
BUY$38.2B65.93%71.9612.55%NA
BUY$118.5B144.05%27.735.51%NA
BUY$64.2B13.51%14.9529.65%0.59%

Stock Returns calculator for Vir Biotechnology Common Stock Stock including INR - Dollar returns

The Vir Biotechnology Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Vir Biotechnology Common Stock investment value today

Current value as on today

₹2,09,845

Returns

₹1,09,845

(+109.85%)

Returns from Vir Biotechnology Common Stock Stock

₹90,512 (+90.51%)

Dollar Impact

₹19,333 (+19.33%)

Analyst Recommendation on Vir Biotechnology Common Stock Stock

Based on 13 analysts

BUY

69.23%

Buy

30.77%

Hold

0.00%

Sell

Based on 13 analysts, 69.23% of analysts recommend a 'BUY' rating for Vir Biotechnology Common Stock. Average target price of $21.56

Vir Biotechnology Common Stock Share Price Target

Get share price movements and forecasts by analysts on Vir Biotechnology Common Stock.

What analysts predicted

53.43%UPSIDE

Target Price

$21.56

Current Price

$10.04

Analyzed by

13 Analysts

Target

$21.56

Vir Biotechnology Common Stock target price $21.56, a slight upside of 53.43% compared to current price of $10.04. According to 13 analysts rating.

Indian Investors' Interest in Vir Biotechnology Common Stock Stock

Search interest for Vir Biotechnology Common Stock Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-28% versus previous 30 day period

Vir Biotechnology Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
16
56
3
2
12
3
1
0
64
0
Gross Profit
-89
-42
-102
-192
-76
-114
-96
-151
430
-2
Operating Income
-139
-80
-158
-231
-117
-139
-118
-173
-36
-133
EBITDA
-126
-73
-128
-215
-100
-135
-115
-159
-40
-122
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
4
4
4
2
2
2
2
2
2
2
Income Before Tax
-120
-65
-139
-213
-104
-120
-110
-162
-43
-125
Income Tax Expense
-4
0
-1
0
0
0
0
0
0
0
Net Income
-115
-65
-138
-213
-104
-120
-110
-163
-42
-125
Net Profit Margin
-690.85%
-115.79%
-4500.10%
-8979.71%
-845.23%
-3989.61%
-9139.87%
-67975.42%
-66.99%
433431.03%

Vir Biotechnology Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
76
1,095
1,615
86
74
68
Gross Profit
-62
-99
0
76
581
994
-486
-404
56
Operating Income
-81
-118
-177
-296
420
833
-684
-587
-468
EBITDA
-81
-115
-173
514
555
761
-641
-508
-426
Interest Expense
-
-
7
3
272
183
-
-
-
Depreciation
0
2
4
5
5
6
16
14
11
Income Before Tax
-80
-116
-174
-298
549
754
-628
-523
-437
Income Tax Expense
-10
0
0
0
21
238
-13
-1
0
Net Income
-69
-115
-174
-298
528
515
-615
-521
-437
Net Profit Margin
-46880.54%
-13350.69%
-24568.64%
-391.09%
48.25%
31.92%
-713.69%
-703.40%
-638.87%

Vir Biotechnology Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-65
-138
-213
-104
-120
-110
-163
-42
-125
Operating Cash Flow
-109
-77
-171
-87
-78
-120
-167
-25
-132
Investing Cash Flow
28
211
118
140
126
56
40
86
11
Financing Cash Flow
0
2
0
1
0
2
0
1
162
Change in Cash
-80
136
-52
54
49
-61
-127
61
41

Vir Biotechnology Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-115
-174
-298
528
515
-615
-521
-437
Operating Cash Flow
-94
-129
-190
-47
1,663
-778
-446
-391
Investing Cash Flow
-60
-256
-9
-140
-1,193
164
499
310
Financing Cash Flow
24
449
529
100
34
7
4
3
Change in Cash
-129
63
328
-88
504
-606
57
-77

Global Institutional Holdings in Vir Biotechnology Common Stock

Funds
Holdings
FMR Inc
1.23%
Soleus Capital Management, L.P.
1.19%
Bank of America Corp
0.55%
Balyasny Asset Management LLC
0.81%
Millennium Management LLC
0.59%

Insights on Vir Biotechnology Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, VIR stock has moved up by 9.2%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, VIR has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vir Biotechnology, Inc. Common Stock has experienced a drawdown of -58.6%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 37.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -42.92M → -125.69M (in $), with an average decrease of 192.8% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 64.07M → -29.0K (in $), with an average decrease of 100.1% per quarter

About Vir Biotechnology Common Stock

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
OrganisationVir Biotechnology Common Stock
Headquarters1800 Owens Street, San Francisco, CA, United States, 94158
IndustryBiotechnology
CEODr. Marianne De Backer M.B.A., M.Sc., Ph.D.
E-voting on sharesClick here to vote

Key Management of Vir Biotechnology Common Stock

Name

Title

Ms. Vanina de Verneuil J.D.

Executive VP, General Counsel & Corporate Secretary

Dr. Lawrence Corey M.D.

Co-Founder & Scientific Advisor

Dr. Maninder Hora Ph.D.

Executive VP & Chief Technical Operations Officer

Mr. Jason O'Byrne M.B.A.

Executive VP & CFO

Dr. Louis J. Picker M.D.

Co-Founder & Scientific Advisor

Mr. Brent Sabatini

Senior VP, Principal Accounting Officer & Chief Accounting Officer

Dr. Jennifer Eileen Towne Ph.D.

Executive VP & Chief Scientific Officer

Dr. Kiki Patel Pharm.D.

Head of Investor Relations

Ms. Carolyn Wang

Senior Vice President of Corporate Communications

Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.

President, CEO & Director

FAQs

What is Vir Biotechnology Common Stock share price today?

Vir Biotechnology Common Stock share price today is $10.04 as on . Vir Biotechnology Common Stock share today touched a day high of $10.38 and a low of $10.01.

What is the 52 week high and 52 week low for Vir Biotechnology Common Stock share?

Vir Biotechnology Common Stock share touched a 52 week high of $11.66 on and a 52 week low of $4.16 on . Vir Biotechnology Common Stock stock price today i.e. is trending at $10.04,which is 13.89% down from its 52 week high and 141.64% up from its 52 week low.

What is Vir Biotechnology Common Stock's market capitalisation today?

Vir Biotechnology Common Stock market capitalisation is $0.00T as on .

How to invest in Vir Biotechnology Common Stock Stock (VIR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vir Biotechnology Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vir Biotechnology Common Stock Shares that will get you 0.1494 shares as per Vir Biotechnology Common Stock share price of $10.04 per share as on June 24, 2026 at 10:58 pm IST.

What is the minimum amount required to buy Vir Biotechnology Common Stock Stock (VIR) from India?

Indian investors can start investing in Vir Biotechnology Common Stock (VIR) shares with as little as ₹94.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.65 in Vir Biotechnology Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Vir Biotechnology Common Stock share’s latest price of $10.04 as on June 24, 2026 at 10:58 pm IST, you will get 0.9960 shares of Vir Biotechnology Common Stock. Learn more about fractional shares .

What are the returns that Vir Biotechnology Common Stock has given to Indian investors in the last 5 years?

Vir Biotechnology Common Stock stock has given -79.51% share price returns and 27.62% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?